These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10606874)

  • 1. Flow cytometric detection of CD10 (cALLA) on peripheral blood B lymphocytes of neonates.
    Brady KA; Atwater SK; Lowell CA
    Br J Haematol; 1999 Dec; 107(4):712-5. PubMed ID: 10606874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human basophils express CD22 without expression of CD19.
    Han K; Kim Y; Lee J; Lim J; Lee KY; Kang CS; Kim WI; Kim BK; Shim SI; Kim SM
    Cytometry; 1999 Nov; 37(3):178-83. PubMed ID: 10520197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing CD43 expression in haematogones using multicolor flow cytometric analysis.
    Tsao L; Colovai AI; Jiang JG; Bhagat G; Alobeid B
    Br J Haematol; 2005 Mar; 128(6):820-3. PubMed ID: 15755286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor modulators of B-cell receptor signalling--CD19/CD22.
    Smith KG; Fearon DT
    Curr Top Microbiol Immunol; 2000; 245(1):195-212. PubMed ID: 10533314
    [No Abstract]   [Full Text] [Related]  

  • 5. CD19 and CD22 regulate a B lymphocyte signal transduction pathway that contributes to autoimmunity.
    Tedder TF; Sato S; Poe JC; Fujimoto M
    Keio J Med; 2000 Mar; 49(1):1-13. PubMed ID: 10750375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.
    Bobbitt KR; Justement LB
    J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
    Hurwitz CA; Gore SD; Stone KD; Civin CI
    Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.
    Poe JC; Hasegawa M; Tedder TF
    Int Rev Immunol; 2001; 20(6):739-62. PubMed ID: 11913948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
    Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
    Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro detection of Mycoplasma fermentans binding to B-lymphocytes in fresh peripheral blood using flow cytometry.
    Cheek RF; Olszak I; Madoff S; Preffer FI
    Cytometry; 1997 May; 28(1):90-5. PubMed ID: 9136760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin.
    Tooze RM; Doody GM; Fearon DT
    Immunity; 1997 Jul; 7(1):59-67. PubMed ID: 9252120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-receptors on B lymphocytes.
    Tsubata T
    Curr Opin Immunol; 1999 Jun; 11(3):249-55. PubMed ID: 10375550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of CD22 (Leu 14) and CD11c (LeuM5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis.
    Miller ML; Fishleder AJ; Tubbs RR
    Am J Clin Pathol; 1991 Jul; 96(1):100-8. PubMed ID: 2069128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes.
    Razi N; Varki A
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7469-74. PubMed ID: 9636173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of percentage of lymphocytes B with expression of co-receptors CD 40, CD22 and CD72 in hypertrophied adenoid at children with otitis media with effusion].
    Wysocka J; Zelazowska-Rutkowska B; Ratomski K; Skotnicka B; Hassmann-Poznańska E
    Otolaryngol Pol; 2009; 63(6):504-8. PubMed ID: 20198985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparameter flow cytometric analysis of human fetal bone marrow B cells.
    LeBien TW; Wörmann B; Villablanca JG; Law CL; Steinberg LM; Shah VO; Loken MR
    Leukemia; 1990 May; 4(5):354-8. PubMed ID: 1697009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic heterogeneity of TDT+ cells in the blood and bone marrow: implications for surveillance of residual leukemia.
    Smith RG; Kitchens RL
    Blood; 1989 Jul; 74(1):312-9. PubMed ID: 2473798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22.
    Fearon DT
    Adv Exp Med Biol; 1998; 452():181-4. PubMed ID: 9889972
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human B-cell lines: an immunofluorescence and immunoelectron microscopy study.
    Pulczynski S; Boesen AM; Jensen OM
    Blood; 1993 Mar; 81(6):1549-57. PubMed ID: 7680920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of B lymphocytes: integrating signals from CD19, CD22 and Fc gamma RIIb1.
    Doody GM; Dempsey PW; Fearon DT
    Curr Opin Immunol; 1996 Jun; 8(3):378-82. PubMed ID: 8793993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.